for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

UPDATE 1-Canada's Resverlogix names Bayer CEO to board

* Higgins is CEO at Bayer Healthcare

* a 32-year veteran of pharmaceuticals industry (Adds details)

TORONTO, Feb 1 (Reuters) - Resverlogix Corp RVX.TO, a small Canadian biotech company, named Bayer HealthCare BAYGn.DE Chief Executive Arthur Higgins to its board of directors on Monday.

The appointment of Higgins, a 32-year veteran in the pharmaceuticals industry, is effective immediately.

Higgins, who joined Bayer in 2004, played a key role in the company’s 2006 acquisition of German drugmaker Schering Ag. (Reporting by Scott Anderson; editing by Peter Galloway)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up